NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Dev Accelerator Enters Bengaluru's Commercial Office Market

Bengaluru: Dev Accelerator Ltd, a managed workspace provider, has made a significant move into India's largest commercial office market by leasing 111,000 square feet in two premium properties of the Prestige Group.

The Prestige Group, a well-established real estate developer, has seen significant interest from managed workspace providers looking to expand their presence in Bengaluru. With this lease, Dev Accelerator Ltd is poised to take advantage of the city's thriving business ecosystem.

The 111,000 square feet of leased space in the Prestige Group's properties highlights the growing demand for managed workspaces in Bengaluru. As a key player in the managed workspace market, Dev Accelerator Ltd's entry into the city is a significant development that will likely have a ripple effect on the commercial office market.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.